Details
Mounjaro Kwikpen 12.5Mg Sol For Diabetic Injection In Pre-Filled 1 Pen
- Mounjaro is a once-weekly, subcutaneous injection that contains tirzepatide, a dual GIP/GLP-1 receptor agonist. The 12.5 mg strength is commonly used as the third dose. The pre-filled, single-use pen is designed for at-home administration with a simple, discreet injection experience when used exactly as prescribed.
Benefits:
- Helps support weight reduction when combined with diet and exercise.
- Helps improve blood-sugar control in adults with type 2 diabetes, when used along with a balanced diet and regular physical activity.
- The once-weekly schedule can support adherence, because you inject on the same day each week.
Main Ingredient & Its Benefits:
- Tirzepatide: A dual agonist of the GIP and GLP-1 receptors. By acting on both pathways, tirzepatide helps the body enhance glucose-dependent insulin secretion, decrease glucagon levels, and slow gastric emptying, which together contribute to better post-meal and overall glycaemic control.
